Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prida Malasit

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Vaccine|September 19, 2015
Generation and preclinical immunogenicity study of dengue type 2 virus-like particles derived from stably transfected mosquito cellsAmporn Suphatrakul, Thippawan Yasanga, Poonsook Keelapang, et al.
Nature Medicine|June 17, 2003
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic feverJuthathip Mongkolsapaya, Wanwisa Dejnirattisai, Xiao-ning Xu, et al.
Viruses|August 10, 2021
Potential Phosphorylation of Viral Nonstructural Protein 1 in Dengue Virus InfectionThanyaporn Dechtawewat, Sittiruk Roytrakul, Yodying Yingchutrakul, et al.
Urology|November 12, 2010
Prothrombin haplotype associated with kidney stone disease in Northeastern Thai patientsNanyawan Rungroj, Suchai Sritippayawan, Wanna Thongnoppakhun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 19, 2021
Ivermectin Accelerates Circulating Nonstructural Protein 1 (NS1) Clearance in Adult Dengue Patients: A Combined Phase 2/3 Randomized Double-blinded Placebo Controlled TrialYupin Suputtamongkol, Panisadee Avirutnan, Dumrong Mairiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?Juthathip Mongkolsapaya, Thaneeya Duangchinda, Wanwisa Dejnirattisai, et al.
Molecular Medicine Reports|August 2, 2013
Vascular endothelial growth factor ‑634G/C polymorphism is associated with increased breast cancer risk and aggressivenessDoonyapat Sa-Nguanraksa, Tuenjai Chuangsuwanich, Tawatchai Pongpruttipan, et al.
Journal of Virology|June 4, 2010
Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particlesJiraphan Junjhon, Thomas J Edwards, Utaiwan Utaipat, et al.
Nature Immunology|October 17, 2018
Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virusMax Renner, Aleksandra Flanagan, Wanwisa Dejnirattisai, et al.
Plos One|March 9, 2026
Correction: Prognostic prediction of dengue hemorrhagic fever in pediatric patients with suspected dengue infection: A multi-site studyMyat Su Yin, Peter Haddawy, Panhavath Meth, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Vaccine|September 19, 2015
Generation and preclinical immunogenicity study of dengue type 2 virus-like particles derived from stably transfected mosquito cellsAmporn Suphatrakul, Thippawan Yasanga, Poonsook Keelapang, et al.
Nature Medicine|June 17, 2003
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic feverJuthathip Mongkolsapaya, Wanwisa Dejnirattisai, Xiao-ning Xu, et al.
Viruses|August 10, 2021
Potential Phosphorylation of Viral Nonstructural Protein 1 in Dengue Virus InfectionThanyaporn Dechtawewat, Sittiruk Roytrakul, Yodying Yingchutrakul, et al.
Urology|November 12, 2010
Prothrombin haplotype associated with kidney stone disease in Northeastern Thai patientsNanyawan Rungroj, Suchai Sritippayawan, Wanna Thongnoppakhun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 19, 2021
Ivermectin Accelerates Circulating Nonstructural Protein 1 (NS1) Clearance in Adult Dengue Patients: A Combined Phase 2/3 Randomized Double-blinded Placebo Controlled TrialYupin Suputtamongkol, Panisadee Avirutnan, Dumrong Mairiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?Juthathip Mongkolsapaya, Thaneeya Duangchinda, Wanwisa Dejnirattisai, et al.
Molecular Medicine Reports|August 2, 2013
Vascular endothelial growth factor ‑634G/C polymorphism is associated with increased breast cancer risk and aggressivenessDoonyapat Sa-Nguanraksa, Tuenjai Chuangsuwanich, Tawatchai Pongpruttipan, et al.
Journal of Virology|June 4, 2010
Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particlesJiraphan Junjhon, Thomas J Edwards, Utaiwan Utaipat, et al.
Nature Immunology|October 17, 2018
Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virusMax Renner, Aleksandra Flanagan, Wanwisa Dejnirattisai, et al.
Plos One|March 9, 2026
Correction: Prognostic prediction of dengue hemorrhagic fever in pediatric patients with suspected dengue infection: A multi-site studyMyat Su Yin, Peter Haddawy, Panhavath Meth, et al.
Pageof 11